OSTUZZI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.508
EU - Europa 4.172
AS - Asia 3.290
SA - Sud America 494
AF - Africa 137
OC - Oceania 19
Totale 12.620
Nazione #
US - Stati Uniti d'America 4.391
RU - Federazione Russa 1.921
SG - Singapore 1.439
CN - Cina 752
IT - Italia 557
GB - Regno Unito 554
BR - Brasile 392
VN - Vietnam 341
HK - Hong Kong 323
DE - Germania 211
SE - Svezia 188
FR - Francia 183
IE - Irlanda 183
FI - Finlandia 139
KR - Corea 105
CA - Canada 80
IN - India 65
ID - Indonesia 52
ES - Italia 38
UA - Ucraina 38
AR - Argentina 34
BD - Bangladesh 34
NL - Olanda 33
PL - Polonia 29
ZA - Sudafrica 29
IQ - Iraq 27
NG - Nigeria 26
AT - Austria 25
MX - Messico 24
TG - Togo 23
BJ - Benin 22
JP - Giappone 20
VE - Venezuela 18
TR - Turchia 16
PK - Pakistan 15
BE - Belgio 14
CO - Colombia 13
AU - Australia 12
SA - Arabia Saudita 12
EC - Ecuador 10
PH - Filippine 10
UZ - Uzbekistan 10
MA - Marocco 9
IL - Israele 8
KE - Kenya 8
LT - Lituania 8
TW - Taiwan 8
UY - Uruguay 8
CL - Cile 7
DK - Danimarca 7
MY - Malesia 7
NZ - Nuova Zelanda 7
CZ - Repubblica Ceca 6
NP - Nepal 6
PE - Perù 6
ET - Etiopia 5
GR - Grecia 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
LB - Libano 4
PS - Palestinian Territory 4
PY - Paraguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
MD - Moldavia 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AO - Angola 2
BO - Bolivia 2
BW - Botswana 2
CM - Camerun 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IR - Iran 2
IS - Islanda 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
Totale 12.609
Città #
Singapore 749
Moscow 640
Ashburn 616
San Jose 512
Dallas 459
Chandler 411
Southend 397
Hong Kong 313
Verona 263
Dublin 167
Beijing 154
The Dalles 152
New York 136
Houston 125
Jacksonville 115
Los Angeles 112
Ho Chi Minh City 97
Woodbridge 73
Lawrence 64
Princeton 64
Wilmington 64
Ann Arbor 62
Munich 59
Helsinki 57
Hanoi 56
Santa Clara 54
Buffalo 49
London 46
Dong Ket 41
Jakarta 41
Redondo Beach 41
Seattle 39
Columbus 38
São Paulo 37
Boardman 35
Chicago 32
Jinan 32
Lappeenranta 31
Kent 27
Nanjing 27
Abuja 26
Council Bluffs 26
Sindelfingen 26
Milan 25
Toronto 25
Lomé 23
Shenyang 23
Warsaw 23
Boston 22
Cotonou 22
Frankfurt am Main 21
Redwood City 21
Tianjin 21
Turku 21
Zhengzhou 21
Atlanta 20
Nuremberg 20
Dearborn 19
Montreal 19
Washington 19
Amsterdam 18
Denver 18
Phoenix 18
Tokyo 18
Johannesburg 17
Rome 17
Manchester 16
Orem 16
Poplar 15
San Francisco 15
Vienna 15
Brooklyn 14
Chennai 14
Hebei 14
Redmond 14
Brussels 13
Guangzhou 13
Haikou 13
Nanchang 13
Stockholm 13
Haiphong 12
Mexico City 12
Belo Horizonte 11
Da Nang 11
Düsseldorf 11
Jiaxing 11
Ningbo 11
Norwalk 11
Rio de Janeiro 11
Baghdad 10
Hangzhou 10
Madrid 10
Taizhou 10
Padova 9
Roverbella 9
Tashkent 9
Buenos Aires 8
Caracas 8
Falkenstein 8
Hải Dương 8
Totale 7.434
Nome #
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 475
A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD 228
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 224
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 219
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 198
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 190
Antipsychotic drug exposure and risk of myocardial infarction 186
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 185
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 184
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 183
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 180
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies 179
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 179
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 174
Antidepressants for the treatment of depression in people with cancer 170
Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials 169
First-generation antipsychotics and QTc: any role for mediating variables? 166
Implementation of treatment guidelines for specialist mental health care 161
Antipsychotic combinations in schizophrenia 160
Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies 158
Effectiveness of Self-Help Plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial 158
Comparing long-acting antipsychotic discontinuation rates under ordinary clinical circumstances: a survival analysis from an observational, pragmatic study 157
Can we identify the active ingredients of behaviour change interventions for coronary heart disease patients? A systematic review and meta-analysis 153
Can a digital medicine system improve adherence to antipsychotic treatment? 153
Comparative efficacy and acceptability of psychosocial interventions for PTSD, depression, and anxiety in asylum seekers, refugees, and other migrant populations: a systematic review and network meta-analysis of randomised controlled studies 151
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies 151
Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure 149
Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study 148
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants 148
Long-acting antipsychotics: patient’s features and prescribing attitudes in Italy. Findings from the cross-sectional phase of an observational, longitudinal, multicenter study. 147
Effectiveness of a stepped-care programme of WHO psychological interventions in migrant populations resettled in Italy: study protocol for the RESPOND randomized controlled trial 145
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial 145
Umbrella systematic review and meta-analysis: physical activity as an effective therapeutic strategy for improving psychosocial outcomes in children and adolescents 144
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review 136
Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy 136
Treatment of locally advanced rectal cancer in the era of total neoadjuvant therapy: a systematic review and network meta-analysis 135
Prevalence and Correlates of Psychological Distress and Psychiatric Disorders in Asylum Seekers and Refugees Resettled in an Italian Catchment Area 135
Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance 134
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 133
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study 133
Cost-effectiveness of the Self-Help Plus Intervention for Adult Syrian Refugees Hosted in Turkey 133
Antidepressants for the treatment of depression in people with cancer 131
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries 130
CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials 129
Public health psychopharmacology: a new research discipline comes of age? 129
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations 127
Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD) 124
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders 123
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study 123
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study 122
Effects of COVID-19 pandemic on psychiatric and psychological consultation-liaison contacts in a general hospital in North-East of Italy: a retrospective study 119
Esketamine for treatment resistant depression: a trick of smoke and mirrors? 118
Effectiveness of a WHO self-help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial 118
Effectiveness of a stepped-care programme of WHO psychological interventions in a population of migrants: results from the RESPOND randomized controlled trial 117
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review 116
Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials 116
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial 115
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base 114
Efficacy of interventions to reduce coercive treatment in mental health services: umbrella review of randomised evidence 113
Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO spontaneous reporting database 112
Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis 110
Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials 109
Medicine-based evidence: the case of antidepressants in patients with coronary artery disease 108
Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study 104
SSRI plus supportive care more effective than supportive care alone for mild to moderate depression 103
Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis 103
Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis 102
Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis 101
Vortioxetine for depression in adults 101
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 99
Esketamine clinical trials: reply to Maju et al 97
Association between sleep disturbances and suicidal behavior in adolescents: a systematic review and meta-analysis 96
Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health 96
Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study 94
Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia 91
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis 91
Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study 90
Association between adverse childhood experiences and suicidal behavior in affective disorders: A systematic review and meta-analysis 89
Regulatory meta-analyses for the evaluation of psychotropic medicines 87
The role of attitudes toward medication and treatment adherence in the clinical response to LAIs: findings from the STAR Network Depot Study 87
Risk factors for mental disorder development in asylum seekers and refugees resettled in Western Europe and Turkey: Participant-level analysis of two large prevention studies 85
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study 85
Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms 85
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches 81
Are sleep disturbances a risk factor for suicidal behavior in the first episode of psychosis? Evidence from a systematic review 79
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations 77
Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study 76
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database 76
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries 75
Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders 71
Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses 68
Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials 67
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions? 66
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries 65
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level 65
Preventing relapse in schizophrenia needs better evidence 64
Factors associated with medication adherence to long-acting injectable antipsychotics: results from the STAR Network Depot Study 58
Combining randomised and observational evidence in schizophrenia: how real is the real world? 54
Expanding access to long-acting antipsychotics in low-income and middle-income countries 54
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines 52
Totale 12.649
Categoria #
all - tutte 44.037
article - articoli 43.674
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 363
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 0 0 0 0 27 42 81
2021/2022494 21 76 2 45 66 9 17 35 24 14 52 133
2022/20231.291 73 133 101 202 111 268 33 100 167 30 43 30
2023/2024909 58 69 65 87 109 143 42 67 19 47 117 86
2024/20252.308 108 97 119 377 136 117 93 115 345 227 192 382
2025/20266.341 453 255 532 1.090 1.715 434 640 382 499 341 0 0
Totale 12.796